TH cell diversity and response to dupilumab in patients with atopic dermatitis - 04/02/21
Doi : 10.1016/j.jaci.2020.05.037
Coline Trichot, PhD a, b, Lilith Faucheux, MSc b, c, Léa Karpf, MSc a, b, Maximilien Grandclaudon, PhD a, Lucia Pattarini, PhD a, Martine Bagot, MD, PhD d, e, Thibault Mahévas, MD d, e, Marie Jachiet, MD d, e, Anne Saussine, MD d, e, Jean-David Bouaziz, MD, PhD d, e, Vassili Soumelis, MD, PhD a, b 
a Institut Curie, PSL University, INSERM U932, Paris, France
b Université de Paris, INSERM U976, Human Systemic Immunology and Inflammatory Network Team, Paris, France
c Université de Paris, INSERM UMR-1153, ECSTRRA Team, Paris, France
d Université de Paris, INSERM U976, Skin Immunity and Inflammation Team, Paris, France
e APHP, Dermatology Department, Hôpital Saint-Louis, Paris, France
| Supported by grants INSERM HTE2016, Ligue Nationale contre le cancer EL2016.LNCC/VaS, ANR-10-IDEX-0001-02 PSL∗, ANR-11-LABX-0043, ANR-15-CHIN-0002, ANR-17-CE14-0025-02, and CIC IGR-Curie 1428. C.T. was supported by ANRT, M.G. received support from ANRS, L.K. and L.F. are supported by a fellowship from the French Ministry of Research. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interests. |
© 2020
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 147 - N° 2
P. 756-759 - février 2021 Retour au numéro
Article précédent
- Drug allergy to CFTR modulator therapy associated with lumacaftor-specific CD4+ T lymphocytes
- Jobst F. Roehmel, Monday O. Ogese, Alexander Rohrbach, Marcus A. Mall, Dean J. Naisbitt
- Psoriasis-associated impairment of CCL27/CCR10-derived regulation leads to IL-17A/IL-22–producing skin T-cell overactivation
- Chao Li, Ming Xu, James Coyne, Wei-Bei Wang, Micha L. Davila, Yong Wang, Na Xiong
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?